Research Areas

An 18-Week, Randomized, Double Blind, Multicenter, Comparator Study of Two Doses of An Oral Investigational Insulin and Placebo with Background Metformin Treatment in Patients with Type 2 Diabetes Mellitus

A Randomized, Placebo-Controlled, 2-Arm Parallel-Group, Multicenter Study With a 24-Week Main Treatment Period and an Extension Assessing the Efficacy and Safety of An Investigational Medication in Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin.

A Multicentre, Randomised, Open Label, Crossover Study to Explore Effectiveness, Safety and Preference of a An Investigational Insulin Delivery Device vs. FlexPen in Subjects with Type 1 or Type 2 Diabetes

A Phase 2b/3, Multicenter, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Clinical Trial of An Investigational Medication in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Insulin

A Phase 2a, Multicenter, Double Blind, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of An Investigational Medication in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control

The Effects of An Investigational Inhaled Medication vs. Placebo on Blood Glucose Control in Patient Volunteers with Type 2 Diabetes Mellitus Currently Treated with Basal Insulin and Oral Antidiabetic Medications, Excluding Secretagogues, in a Phase IIa, Randomized, Parallel, Double Blind, Placebo Controlled, Multicenter Study

A Phase 2a, Multicenter, Double-Blind, Randomized, Active Controlled, Parallel Arm Clinical Trial to Study the Efficacy and Safety of An Investigational Medication Compared to Sulfonylurea in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Therapy

A 26 Week Randomized, Multinational, Open Label, 2 Armed, Parallel Group, Treat-to-Target Once Daily Treatment Trial with an Approved Insulin versus Insulin Glargine, Both in Combination with Metformin in Subjects with Type 2 Diabetes

12-week, Multinational, Multicenter, Controlled, Open, 1:1:1 Randomized, Parallel Clinical Trial to Assess Noninferiority Between Pre- and Post-Meal Administration of an Investigational Insulin and Pre-Meal Regular Human Insulin in Subjects with Type 1 Diabetes Mellitus Receiving Insulin Glargine as the Basal Insulin Therapy.

A 52-Week Randomised, Controlled, Open Label, Multicentre, Multinational Treat-to-Target Trial Comparing Efficacy and Safety of An Investigational Insulin and Insulin Glargine Both Administered Once Daily in a Basal-Bolus Regimen with Insulin Aspart as Mealtime Insulin in Subjects with Type 1 Diabetes

Collection of normal blood sample for use in vaccine development

A Multicenter, Randomized, Double-Blind, Long Term Study of the Safety of Subcutaneous Administration of An Investigational Medication in Patients with Osteoarthritis of the Knee or Hip

Dose Response, Efficacy, and Safety of an Investigational Medication: A 12-Week Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel-Group Study of Metformin and Five Doses of and Investigational Medication in Previously Treated OHA Monotherapy Obese Subjects With Type 2 Diabetes

A Phase III, Multicenter, Two-Arm Study to Assess the Efficacy and Safety of An Investigational Oral Medication in the Treatment of Obesity in Subjects With Hypertension and/or Dyslipidemia

A Phase III, 12-month, double blind, randomized, parallel group, placebo controlled, efficacy and safety study of an investigational medication in overweight and obese subjects with a 12-month open-label extension phase.

A randomized, double-blind, placebo-controlled, parallel-group, fixed-dose, multicenter study of weight-reducing and prevention of weight regain effects and safety of an investigational drug in obese patients with or without comorbidities.

Effect of Renal Impairment on Pharmacodynamics and Pharmokinetics of An Investigational Medication: A Multiple-Center, Open-Label, Parallel Group Study Following Single Oral Dosing of RO4998452 to Type 2 Diabetes Patients With Varying Degrees of Renal Impairment.

A Multicenter, Efficacy and Safety Assessment of Two Different Dose Levels of An Investigative Topical Gel in Patients With Painful Diabetic Neuropathy

A Phase II Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of An Investigational Medication In Subjects With Diabetic Neuropathy

A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Efficacy and Safety of an Investigational Medication in Painful Diabetic Neuropathy